- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.71 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 7 residues within 4Å:- Chain A: V.20, D.21, R.314, L.315, V.316
- Chain B: V.100, N.104
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: A.62, D.92, L.93, D.98, F.99, Y.102
Ligand excluded by PLIPEDO.4: 8 residues within 4Å:- Chain A: G.97, D.98, H.184, R.216, R.229, E.231
- Chain E: T.208, N.210
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: W.64, F.74, I.75, N.76, V.77, F.115, K.117, Y.258
Ligand excluded by PLIPEDO.7: 1 residues within 4Å:- Chain A: Q.119
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain B: W.14, H.25, Y.34
- Ligands: GOL.9
Ligand excluded by PLIPEDO.11: 1 residues within 4Å:- Ligands: EDO.12
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain B: Q.42, D.46
- Chain C: N.31, Y.32, G.100, N.101
- Ligands: EDO.11
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain B: D.46, T.49, N.50
- Chain C: T.28, N.31
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain B: A.36, D.37, K.38, E.39, R.153
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain B: D.19, A.36, K.38
- Chain C: N.101, Y.102, Y.103, Y.105
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain E: V.20, D.21, R.314, L.315, V.316
- Chain F: V.100, N.104
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain E: A.62, D.92, L.93, D.98, F.99, Y.102
Ligand excluded by PLIPEDO.20: 8 residues within 4Å:- Chain E: G.97, D.98, H.184, R.216, R.229, E.231
- Chain I: T.208, N.210
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain E: W.64, F.74, I.75, N.76, V.77, F.115, K.117, Y.258
Ligand excluded by PLIPEDO.23: 1 residues within 4Å:- Chain E: Q.119
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain F: W.14, H.25, Y.34
- Ligands: GOL.25
Ligand excluded by PLIPEDO.27: 1 residues within 4Å:- Ligands: EDO.28
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain F: Q.42, D.46
- Chain G: N.31, Y.32, G.100, N.101
- Ligands: EDO.27
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain F: D.46, T.49, N.50
- Chain G: T.28, N.31
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain F: A.36, D.37, K.38, E.39, R.153
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain F: D.19, A.36, K.38
- Chain G: N.101, Y.102, Y.103, Y.105
Ligand excluded by PLIPEDO.34: 7 residues within 4Å:- Chain I: V.20, D.21, R.314, L.315, V.316
- Chain J: V.100, N.104
Ligand excluded by PLIPEDO.35: 6 residues within 4Å:- Chain I: A.62, D.92, L.93, D.98, F.99, Y.102
Ligand excluded by PLIPEDO.36: 8 residues within 4Å:- Chain A: T.208, N.210
- Chain I: G.97, D.98, H.184, R.216, R.229, E.231
Ligand excluded by PLIPEDO.37: 8 residues within 4Å:- Chain I: W.64, F.74, I.75, N.76, V.77, F.115, K.117, Y.258
Ligand excluded by PLIPEDO.39: 1 residues within 4Å:- Chain I: Q.119
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain J: W.14, H.25, Y.34
- Ligands: GOL.41
Ligand excluded by PLIPEDO.43: 1 residues within 4Å:- Ligands: EDO.44
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain J: Q.42, D.46
- Chain K: N.31, Y.32, G.100, N.101
- Ligands: EDO.43
Ligand excluded by PLIPEDO.45: 5 residues within 4Å:- Chain J: D.46, T.49, N.50
- Chain K: T.28, N.31
Ligand excluded by PLIPEDO.46: 5 residues within 4Å:- Chain J: A.36, D.37, K.38, E.39, R.153
Ligand excluded by PLIPEDO.48: 7 residues within 4Å:- Chain J: D.19, A.36, K.38
- Chain K: N.101, Y.102, Y.103, Y.105
Ligand excluded by PLIP- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 2 residues within 4Å:- Chain A: N.15
- Chain B: Q.15
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:Q.15, A:N.15
- Water bridges: B:Q.15
NAG.8: 1 residues within 4Å:- Chain A: N.27
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.27
NAG.15: 5 residues within 4Å:- Chain B: E.147, E.150, S.151, N.154, T.156
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.147, B:T.156
- Water bridges: B:N.154
NAG.22: 2 residues within 4Å:- Chain E: N.15
- Chain F: Q.15
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain F- Hydrogen bonds: E:N.15, F:Q.15
- Water bridges: F:Q.15
NAG.24: 1 residues within 4Å:- Chain E: N.27
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.27
NAG.31: 5 residues within 4Å:- Chain F: E.147, E.150, S.151, N.154, T.156
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:E.147, F:T.156
- Water bridges: F:N.154
NAG.38: 2 residues within 4Å:- Chain I: N.15
- Chain J: Q.15
3 PLIP interactions:1 interactions with chain I, 2 interactions with chain J- Hydrogen bonds: I:N.15, J:Q.15
- Water bridges: J:Q.15
NAG.40: 1 residues within 4Å:- Chain I: N.27
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:N.27
NAG.47: 5 residues within 4Å:- Chain J: E.147, E.150, S.151, N.154, T.156
3 PLIP interactions:3 interactions with chain J- Hydrogen bonds: J:E.147, J:T.156
- Water bridges: J:N.154
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 4 residues within 4Å:- Chain B: W.14, N.135, C.137
- Ligands: EDO.10
1 PLIP interactions:1 interactions with chain B- Water bridges: B:N.135
GOL.25: 4 residues within 4Å:- Chain F: W.14, N.135, C.137
- Ligands: EDO.26
1 PLIP interactions:1 interactions with chain F- Water bridges: F:N.135
GOL.41: 4 residues within 4Å:- Chain J: W.14, N.135, C.137
- Ligands: EDO.42
1 PLIP interactions:1 interactions with chain J- Water bridges: J:N.135
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dreyfus, C. et al., Highly conserved protective epitopes on influenza B viruses. Science (2012)
- Release Date
- 2012-08-22
- Peptides
- Hemagglutinin HA1: AEI
Hemagglutinin HA2: BFJ
antibody CR9114 heavy chain: CGK
antibody CR9114 light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
HG
HK
HD
LH
LL
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.71 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dreyfus, C. et al., Highly conserved protective epitopes on influenza B viruses. Science (2012)
- Release Date
- 2012-08-22
- Peptides
- Hemagglutinin HA1: AEI
Hemagglutinin HA2: BFJ
antibody CR9114 heavy chain: CGK
antibody CR9114 light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AB
BF
BJ
BC
HG
HK
HD
LH
LL
L